Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.
about
Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptidesSite-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia.Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemiaGene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesPrognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemiaRAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures.Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib responseMolecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemiaAberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic targetNPM1 deletion is associated with gross chromosomal rearrangements in leukemiaIdentification of an ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukaemia cell line.E1A3 as a unique, naturally occurring BCR-ABL transcript in an indolent case of chronic myeloid leukaemia.Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1New data on robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation proceduresGenetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.Prevalence of ETV6/RUNX1 Fusion Gene in Pediatric Patients with Acute Lymphoblastic Leukemia in IranClinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemiaMolecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia.An unusual translocation, t(1;11)(q21;q23), in a case of chronic myeloid leukemia with a cryptic Philadelphia chromosome.Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemiaCD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.Maltose-binding protein enhances secretion of recombinant human granzyme B accompanied by in vivo processing of a precursor MBP fusion protein.A comprehensive analysis of breakpoint cluster region-abelson fusion oncogene splice variants in chronic myeloid leukemia and their correlation with disease biology.Evaluation of a new flow cytometry based method for detection of BCR-ABL1 fusion protein in chronic myeloid leukemia.Proteomic profile of pre - B2 lymphoblasts from children with acute lymphoblastic leukemia (ALL) in relation with the translocation (12; 21)Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: possible involvement in the genesis of the Philadelphia chromosome translocationImpact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia.Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia annotation.A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: a methodological review.Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case StudyEvaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaFrequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients.MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals.Anthracycline dose intensification in acute myeloid leukemia.Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell markerThe CEBPA gene is down-regulated in acute promyelocytic leukemia and its upstream promoter, but not the core promoter, is highly methylated
P2860
Q21090848-B73793AB-3FC1-4C76-B91E-2AD18E6C5D65Q24538611-3DE081A7-0FD8-45F6-8200-DC9E0044B29BQ24604850-63927373-A579-4D00-AD1A-21A9F516E4D1Q24624017-FA87434A-7E8F-4A3F-945E-65A358F45B10Q26828511-961A69F8-E3A2-49FC-9F6B-12B2A24E061CQ27006773-18E88078-1FAE-4D2B-9213-2A9C8C35CAD6Q27852887-07EB9B10-9FA6-40A9-8F97-09D8EC257B27Q27853040-65826B3B-E426-4F58-B479-49B4B2B3BD41Q28219251-2B67B057-A9DD-44AB-B068-B5A29128A45CQ28306608-64BA72D5-D732-443F-9A77-BE2EDAC32644Q28749228-C83C0400-1BBC-4027-A843-4B17B2FE078AQ30165122-F90AB986-B52B-4C6B-8212-EBF8761D7948Q30167929-DC63E72E-6AAC-43E7-AF62-0D9E7D95DA35Q30432285-3F560300-D11A-474E-9CBF-3B89B3EA6866Q31116667-A20F72F3-A89A-434D-8396-53A72C5A94ABQ33555627-B4A08055-BEF1-4019-B789-11339D6B0E46Q33628322-4E0C057C-5B77-4DD9-AB06-34D6CFC36024Q33632230-94AF98FD-1E08-4B80-B66A-D9A50BA6F957Q33654464-93BBE501-CF69-4BD6-9D51-E8CF858ECECCQ33685242-FD36CE99-DC47-4949-9EDE-3ECAA7F521C8Q33710730-4C312F42-F2B1-42A9-9EB7-925422A578E9Q33755327-2203A5E9-0590-4D66-AE30-0EF92244EA39Q33784763-212B159B-1AB5-48C5-9504-6C0537A746FFQ33785880-ADFF51A6-539D-43EB-8C85-F32A2D2D2EACQ33889952-C75A4DF8-0E8B-405C-A6AC-6BBE95635E7BQ34027272-4A675858-19B0-4096-B350-60E4B1F6716DQ34067009-B9DE391E-ED4F-417A-8AA6-3FD132660EB9Q34076060-0CCA8F78-3C22-4FC9-9A45-004679A36313Q34120726-3D4E56FC-BCBD-4414-8975-A1D37564FBB2Q34135330-6714D2C5-A34F-48E9-8DC5-97F9643F9DDCQ34211015-2E2F36A9-61E9-4F2B-9FBF-FDD945515746Q34448334-07346B44-E017-4290-92BB-ABBD14DA70C8Q34480479-82695DAA-07B0-4939-B751-409FE50EAAC6Q34542996-DBC5F748-A2FC-4ACF-B2BB-EFA0E5C025A5Q34565298-485B6342-8494-4B88-985D-422E98DE7B29Q34565527-503192E7-E81D-4BB1-ACAE-B8F2979D21F0Q34612121-81A64BE4-3078-4476-A604-8BD8DA8B8009Q34657243-705E0D97-5FAF-493D-A998-669BB07CB37CQ34720554-4A323B40-1354-45D7-870C-8A5A5AD1A6D8Q34750625-4CD69CC4-770C-4109-B090-D5FF1D56DC6B
P2860
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Standardized RT-PCR analysis o ...... ual disease in acute leukemia.
@ast
Standardized RT-PCR analysis o ...... ual disease in acute leukemia.
@en
type
label
Standardized RT-PCR analysis o ...... ual disease in acute leukemia.
@ast
Standardized RT-PCR analysis o ...... ual disease in acute leukemia.
@en
prefLabel
Standardized RT-PCR analysis o ...... ual disease in acute leukemia.
@ast
Standardized RT-PCR analysis o ...... ual disease in acute leukemia.
@en
P2093
P356
P1433
P1476
Standardized RT-PCR analysis o ...... ual disease in acute leukemia.
@en
P2093
Delabesse E
Gottardi E
Griesinger F
Langerak AW
Macintyre EA
P2888
P304
P356
10.1038/SJ/LEU/2401592
P577
1999-12-01T00:00:00Z
P5875
P6179
1056650564